Paxlovid mouth likely is mediated by activation of the TAS2R1 bitter receptor by nirmatrelvir
Lauren Caronia, Ranhui Xi, Robert F. Margolskee, Peihua Jiang
Topics & Concepts
DysgeusiaRitonavirTasteBitter tastePharmacologyMedicineAdverse effectCoronavirusTaste receptorCoronavirus disease 2019 (COVID-19)DiseaseInternal medicineVirusViral loadBiologyFood scienceVirologyAntiretroviral therapyInfectious disease (medical specialty)Biochemical Analysis and Sensing TechniquesAdvanced Chemical Sensor TechnologiesOlfactory and Sensory Function Studies